Loading…
Ocular Allergic Disease: Mechanisms, Disease Sub-types, Treatment
Ocular allergy refers to a variety of hypersensitivity disorders that affect the lid, conjunctiva, and/or cornea. Its incidence is estimated at over 20% of the general population in the United States. This review will discuss the various forms of ocular allergy, their pathophysiology, clinical prese...
Saved in:
Published in: | The ocular surface 2003-07, Vol.1 (3), p.127-149 |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c276t-6488f4522f09d6f5570eaf0f259b45b91475a7100811d226db7e8510f6af24283 |
---|---|
cites | cdi_FETCH-LOGICAL-c276t-6488f4522f09d6f5570eaf0f259b45b91475a7100811d226db7e8510f6af24283 |
container_end_page | 149 |
container_issue | 3 |
container_start_page | 127 |
container_title | The ocular surface |
container_volume | 1 |
creator | Abelson, Mark B. Smith, Lisa Chapin, Matthew |
description | Ocular allergy refers to a variety of hypersensitivity disorders that affect the lid, conjunctiva, and/or cornea. Its incidence is estimated at over 20% of the general population in the United States. This review will discuss the various forms of ocular allergy, their pathophysiology, clinical presentation, and treatment. New frontiers in mechanisms, therapy, and management in the office are emphasized throughout. |
doi_str_mv | 10.1016/S1542-0124(12)70140-4 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_71608446</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1542012412701404</els_id><sourcerecordid>71608446</sourcerecordid><originalsourceid>FETCH-LOGICAL-c276t-6488f4522f09d6f5570eaf0f259b45b91475a7100811d226db7e8510f6af24283</originalsourceid><addsrcrecordid>eNqFkE1LAzEQhoMofv8EpSdRcHUmzceuFyl-Q8WDeg7Z7EQju21NdoX-e7e24tHTDMPzzjAPYwcIZwiozp9RCp4BcnGM_EQDCsjEGtvGYqgzWeBwve9_kS22k9IHwFAp4JtsCzVoqYTYZqMn19U2DkZ1TfEtuMF1SGQTXQweyb3bSUhNOv0dDp67MmvnM-pHL5Fs29Ck3WMb3taJ9ld1l73e3rxc3Wfjp7uHq9E4c1yrNlMiz72QnHsoKuWl1EDWg-eyKIUsCxRaWo0AOWLFuapKTblE8Mp6Lng-3GVHy72zOP3sKLWmCclRXdsJTbtkNCrIhVA9KJegi9OUInkzi6GxcW4QzMKd-XFnFmIMcvPjzog-d7g60JUNVX-plaweuFwC1L_5FSia5AJNHFUhkmtNNQ3_nPgGSY17nA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71608446</pqid></control><display><type>article</type><title>Ocular Allergic Disease: Mechanisms, Disease Sub-types, Treatment</title><source>Elsevier</source><creator>Abelson, Mark B. ; Smith, Lisa ; Chapin, Matthew</creator><creatorcontrib>Abelson, Mark B. ; Smith, Lisa ; Chapin, Matthew</creatorcontrib><description>Ocular allergy refers to a variety of hypersensitivity disorders that affect the lid, conjunctiva, and/or cornea. Its incidence is estimated at over 20% of the general population in the United States. This review will discuss the various forms of ocular allergy, their pathophysiology, clinical presentation, and treatment. New frontiers in mechanisms, therapy, and management in the office are emphasized throughout.</description><identifier>ISSN: 1542-0124</identifier><identifier>EISSN: 1937-5913</identifier><identifier>DOI: 10.1016/S1542-0124(12)70140-4</identifier><identifier>PMID: 17075644</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>allergic conjunctivitis ; allergic mediators ; antihistamines ; histamine ; lid swelling ; mast cell stabilizers ; mast cells ; ocular allergy ; ocular inflammation ; rhinoconjunctivitis ; steroids</subject><ispartof>The ocular surface, 2003-07, Vol.1 (3), p.127-149</ispartof><rights>2003 Elsevier Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c276t-6488f4522f09d6f5570eaf0f259b45b91475a7100811d226db7e8510f6af24283</citedby><cites>FETCH-LOGICAL-c276t-6488f4522f09d6f5570eaf0f259b45b91475a7100811d226db7e8510f6af24283</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17075644$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Abelson, Mark B.</creatorcontrib><creatorcontrib>Smith, Lisa</creatorcontrib><creatorcontrib>Chapin, Matthew</creatorcontrib><title>Ocular Allergic Disease: Mechanisms, Disease Sub-types, Treatment</title><title>The ocular surface</title><addtitle>Ocul Surf</addtitle><description>Ocular allergy refers to a variety of hypersensitivity disorders that affect the lid, conjunctiva, and/or cornea. Its incidence is estimated at over 20% of the general population in the United States. This review will discuss the various forms of ocular allergy, their pathophysiology, clinical presentation, and treatment. New frontiers in mechanisms, therapy, and management in the office are emphasized throughout.</description><subject>allergic conjunctivitis</subject><subject>allergic mediators</subject><subject>antihistamines</subject><subject>histamine</subject><subject>lid swelling</subject><subject>mast cell stabilizers</subject><subject>mast cells</subject><subject>ocular allergy</subject><subject>ocular inflammation</subject><subject>rhinoconjunctivitis</subject><subject>steroids</subject><issn>1542-0124</issn><issn>1937-5913</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><recordid>eNqFkE1LAzEQhoMofv8EpSdRcHUmzceuFyl-Q8WDeg7Z7EQju21NdoX-e7e24tHTDMPzzjAPYwcIZwiozp9RCp4BcnGM_EQDCsjEGtvGYqgzWeBwve9_kS22k9IHwFAp4JtsCzVoqYTYZqMn19U2DkZ1TfEtuMF1SGQTXQweyb3bSUhNOv0dDp67MmvnM-pHL5Fs29Ck3WMb3taJ9ld1l73e3rxc3Wfjp7uHq9E4c1yrNlMiz72QnHsoKuWl1EDWg-eyKIUsCxRaWo0AOWLFuapKTblE8Mp6Lng-3GVHy72zOP3sKLWmCclRXdsJTbtkNCrIhVA9KJegi9OUInkzi6GxcW4QzMKd-XFnFmIMcvPjzog-d7g60JUNVX-plaweuFwC1L_5FSia5AJNHFUhkmtNNQ3_nPgGSY17nA</recordid><startdate>200307</startdate><enddate>200307</enddate><creator>Abelson, Mark B.</creator><creator>Smith, Lisa</creator><creator>Chapin, Matthew</creator><general>Elsevier Inc</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200307</creationdate><title>Ocular Allergic Disease: Mechanisms, Disease Sub-types, Treatment</title><author>Abelson, Mark B. ; Smith, Lisa ; Chapin, Matthew</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c276t-6488f4522f09d6f5570eaf0f259b45b91475a7100811d226db7e8510f6af24283</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>allergic conjunctivitis</topic><topic>allergic mediators</topic><topic>antihistamines</topic><topic>histamine</topic><topic>lid swelling</topic><topic>mast cell stabilizers</topic><topic>mast cells</topic><topic>ocular allergy</topic><topic>ocular inflammation</topic><topic>rhinoconjunctivitis</topic><topic>steroids</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Abelson, Mark B.</creatorcontrib><creatorcontrib>Smith, Lisa</creatorcontrib><creatorcontrib>Chapin, Matthew</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>The ocular surface</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Abelson, Mark B.</au><au>Smith, Lisa</au><au>Chapin, Matthew</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Ocular Allergic Disease: Mechanisms, Disease Sub-types, Treatment</atitle><jtitle>The ocular surface</jtitle><addtitle>Ocul Surf</addtitle><date>2003-07</date><risdate>2003</risdate><volume>1</volume><issue>3</issue><spage>127</spage><epage>149</epage><pages>127-149</pages><issn>1542-0124</issn><eissn>1937-5913</eissn><abstract>Ocular allergy refers to a variety of hypersensitivity disorders that affect the lid, conjunctiva, and/or cornea. Its incidence is estimated at over 20% of the general population in the United States. This review will discuss the various forms of ocular allergy, their pathophysiology, clinical presentation, and treatment. New frontiers in mechanisms, therapy, and management in the office are emphasized throughout.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>17075644</pmid><doi>10.1016/S1542-0124(12)70140-4</doi><tpages>23</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1542-0124 |
ispartof | The ocular surface, 2003-07, Vol.1 (3), p.127-149 |
issn | 1542-0124 1937-5913 |
language | eng |
recordid | cdi_proquest_miscellaneous_71608446 |
source | Elsevier |
subjects | allergic conjunctivitis allergic mediators antihistamines histamine lid swelling mast cell stabilizers mast cells ocular allergy ocular inflammation rhinoconjunctivitis steroids |
title | Ocular Allergic Disease: Mechanisms, Disease Sub-types, Treatment |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T22%3A36%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Ocular%20Allergic%20Disease:%20Mechanisms,%20Disease%20Sub-types,%20Treatment&rft.jtitle=The%20ocular%20surface&rft.au=Abelson,%20Mark%20B.&rft.date=2003-07&rft.volume=1&rft.issue=3&rft.spage=127&rft.epage=149&rft.pages=127-149&rft.issn=1542-0124&rft.eissn=1937-5913&rft_id=info:doi/10.1016/S1542-0124(12)70140-4&rft_dat=%3Cproquest_cross%3E71608446%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c276t-6488f4522f09d6f5570eaf0f259b45b91475a7100811d226db7e8510f6af24283%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=71608446&rft_id=info:pmid/17075644&rfr_iscdi=true |